Though thousands of flavored and disposable vapes may disappear from store shelves across the country, tobacco prevention and control and health policy experts warn that these bans aren’t enough to protect youth.

These new tobacco products are becoming popular, and it is important to understand the health risks of nicotine pouches. In January, the US Food and Drug Administration (FDA) authorized the marketing and sale of 20 different Zyn nicotine pouch products. This does not mean these products are approved by the FDA as a safe drug. It simply means they’ve allowed the company to sell these tobacco products in the US.

A recent study published in the peer-reviewed Journal of the American Medical Association (JAMA) shows promising results on use of the varenicline (generic Chantix) in adolescents and young adults who vape nicotine. When compared to placebo or behavioral counseling alone, participants taking varenicline had more than three times higher abstinence rates. Overall, varenicline was well tolerated, with only two participants leaving the study due to adverse effects.